MIRA Stock Analysis: Buy, Sell, or Hold?
MIRA - MIRA Pharmaceuticals, Inc. Common Stock
$1.02
-0.02 (-1.46%)
ā¼
5d:
-9.78%
30d:
-20.08%
90d:
-32.78%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: Mar 27, 2026
0d
Get Alerted When MIRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
š HOLD: MIRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
š HOLD: MIRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MIRA is currently trading at $1.01, which is considered oversold relative to its 30-day fair value range of $1.07 to $1.26.
Technical Outlook: Technically, MIRA is in a downtrend. Immediate support is located at $0.90, while resistance sits at $1.22.
Market Sentiment: MIRA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.75 (+1623.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MIRA is in a downtrend. Immediate support is located at $0.90, while resistance sits at $1.22.
Market Sentiment: MIRA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.75 (+1623.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.07 -
$1.26
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1623.3% below Wall St target ($17.75)
- CAUTION: 5-day price weakness (-9.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.07 -
$1.26
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.90
Resistance Level
$1.22
Current Trend
Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.51
Wall Street Target
$17.75
(+1623.3%)
Share & Embed Analysis
Last updated: March 30, 2026 10:26 AM ET
Data refreshes hourly during market hours. Next update: 11:26 AM
Data refreshes hourly during market hours. Next update: 11:26 AM
š„ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MIRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
29 analysts |
$1209 | 51 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$157 | 57 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$206 | 62 BUY |
|
MRK
Merck & Company Inc |
BUY
26 analysts |
$128 | 68 BUY |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$351 | 58 HOLD |
